1 August 2024 false Taxfiler 2024.6 15830911 business:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15830911 2024-07-31 15830911 2024-08-01 2025-07-31 15830911 business:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 15830911 business:FilletedAccounts 2024-08-01 2025-07-31 15830911 2025-07-31 15830911 business:Director1 2024-08-01 2025-07-31 15830911 business:Director2 2024-08-01 2025-07-31 15830911 business:RegisteredOffice 2024-08-01 2025-07-31 15830911 core:ShareCapital core:PreviouslyStatedAmount 2025-07-31 15830911 core:PreviouslyStatedAmount 2025-07-31 15830911 business:SmallEntities 2024-08-01 2025-07-31 15830911 countries:EnglandWales 2024-08-01 2025-07-31 15830911 core:AfterOneYear 2025-07-31 iso4217:GBP xbrli:pure
Company Registration No. 15830911 (England and Wales)
Ksquare Pharma Limited Unaudited accounts for the year ended 31 July 2025
Ksquare Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Ksquare Pharma Limited Company Information for the year ended 31 July 2025
Directors
Dhipal Maulik DESAI Manishkumar SHAH
Company Number
15830911 (England and Wales)
Registered Office
UNIT 17 WESTBURY CLOSE HOUGHTON REGIS LU5 5BL United Kingdom
- 3 -
Ksquare Pharma Limited Statement of financial position as at 31 July 2025
2025
Notes
£
Current assets
Debtors
4
1,000
Net current assets
1,000
Net assets
1,000
Capital and reserves
Called up share capital
1,000
Shareholders' funds
1,000
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 March 2026 and were signed on its behalf by
Manishkumar SHAH Director Company Registration No. 15830911
- 4 -
Ksquare Pharma Limited Notes to the Accounts for the year ended 31 July 2025
1
Statutory information
Ksquare Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15830911. The registered office is UNIT 17, WESTBURY CLOSE, HOUGHTON REGIS, LU5 5BL, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025
£
Amounts falling due after more than one year
Other debtors
1,000
5
Average number of employees
During the year the average number of employees was 0.
- 5 -